Advances in miniature CRISPR-Cas proteins and their applications in gene editing

被引:4
|
作者
Wu, Huimin [1 ,2 ]
Sun, Yixiang [2 ]
Wang, Yimai [1 ,2 ]
Luo, Liqiang [1 ]
Song, Yizhi [2 ,3 ]
机构
[1] Shanghai Univ, Coll Sci, Dept Chem, Shanghai, Peoples R China
[2] Chinese Acad Sci, Suzhou Inst Biomed Engn & Technol, Suzhou, Peoples R China
[3] Univ Sci & Technol China, Sch Biomed Engn, Div Life Sci & Med, Suzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Miniature CRISPR-Cas proteins; Cas12; Gene editing; STRUCTURAL BASIS; DNA; IDENTIFICATION; INTERFERENCE; REPEATS; SYSTEMS; PHI;
D O I
10.1007/s00203-024-03962-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The CRISPR-Cas system consists of Cas proteins and single-stranded RNAs that recruit Cas proteins and specifically target the nucleic acid. Some Cas proteins can accurately cleave the target nucleic acid under the guidance of the single-stranded RNAs. Due to its exceptionally high specificity, the CRISPR-Cas system is now widely used in various fields such as gene editing, transcription regulation, and molecular diagnosis. However, the huge size of the most frequently utilized Cas proteins (Cas9, Cas12a, and Cas13, which contain 950-1,400 amino acids) can limit their applicability, especially in eukaryotic gene editing, where larger Cas proteins are difficult to deliver into the target cells. Recently discovered miniature CRISPR-Cas proteins, consisting of only 400 to 800 amino acids, offer the possibility of overcoming this limitation. This article systematically reviews the latest research progress of several miniature CRISPR-Cas proteins (Cas12f, Cas12j, Cas12k, and Cas12m) and their practical applications in the field of gene editing.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Orthogonal transcriptional modulation and gene editing using multiple CRISPR-Cas systems
    Brokso, Amalie Dyrelund
    Bendixen, Louise
    Famme, Simon
    Mikkelsen, Kasper
    Jensen, Trine Ilso
    Bak, Rasmus O.
    MOLECULAR THERAPY, 2025, 33 (01) : 71 - 89
  • [32] CRISPR-Cas Gene Perturbation and Editing in Human Induced Pluripotent Stem Cells
    van Essen, Max
    Riepsaame, Joey
    Jacob, John
    CRISPR JOURNAL, 2021, 4 (05): : 634 - 655
  • [33] CRISPR-Cas gene editing technology and its application prospect in medicinal plants
    Miaoxian Guo
    Hongyu Chen
    Shuting Dong
    Zheng Zhang
    Hongmei Luo
    Chinese Medicine, 17
  • [34] CRISPR-Cas gene editing technology and its application prospect in medicinal plants
    Guo, Miaoxian
    Chen, Hongyu
    Dong, Shuting
    Zhang, Zheng
    Luo, Hongmei
    CHINESE MEDICINE, 2022, 17 (01)
  • [35] CRISPR-Cas Systems and Genome Editing: Beginning the Era of CRISPR/Cas Therapies for Humans
    Karpov, Dmitry S.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (10)
  • [36] Gene Digital Circuits Based on CRISPR-Cas Systems and Anti-CRISPR Proteins
    Yu, Lifang
    Zhang, Yadan
    Marchisio, Mario Andrea
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2022, (188):
  • [37] Applications of CRISPR-Cas systems in neuroscience
    Heidenreich, Matthias
    Zhang, Feng
    NATURE REVIEWS NEUROSCIENCE, 2016, 17 (01) : 36 - 44
  • [38] Computer-aided engineering of CRISPR-Cas proteins for enhanced human genome editing
    Chen, Yangcan
    Hu, Yanping
    Luo, Shengqiu
    Wang, Xinge
    Mao, Bangwei
    Chen, Yi
    Xu, Jing
    Li, Zhikun
    Zhou, Qi
    Li, Wei
    SCIENCE CHINA-LIFE SCIENCES, 2023, 66 (04) : 883 - 886
  • [39] Computer-aided engineering of CRISPR-Cas proteins for enhanced human genome editing
    Yangcan Chen
    Yanping Hu
    Shengqiu Luo
    Xinge Wang
    Bangwei Mao
    Yi Chen
    Jing Xu
    Zhikun Li
    Qi Zhou
    Wei Li
    Science China(Life Sciences), 2023, 66 (04) : 883 - 886
  • [40] CRISPR-Cas systems for genome editing of mammalian cells
    Mani, Indra
    Arazoe, Takayuki
    Singh, Vijai
    REPROGRAMMING THE GENOME: CRISPR-CAS-BASED HUMAN DISEASE THERAPY, 2021, 181 : 15 - 30